Production (Stage)
enGene Holdings Inc.
ENGN
$3.33
$0.082.46%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 26.58% | 85.02% | 149.76% | 258.78% | 305.85% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 96.44% | 142.66% | 139.05% | 149.51% | 111.04% |
Operating Income | -96.44% | -142.66% | -139.05% | -149.51% | -111.04% |
Income Before Tax | 29.47% | 33.14% | 44.78% | -374.93% | -306.26% |
Income Tax Expenses | 3,000.00% | 323.08% | -211.76% | -195.45% | -63.64% |
Earnings from Continuing Operations | 29.26% | 33.10% | 44.81% | -374.44% | -305.97% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 29.26% | 33.10% | 44.81% | -374.44% | -305.97% |
EBIT | -96.44% | -142.66% | -139.05% | -149.51% | -111.04% |
EBITDA | -96.84% | -143.36% | -139.65% | -150.22% | -111.83% |
EPS Basic | 98.70% | 98.88% | 98.99% | -253.70% | -366.17% |
Normalized Basic EPS | 95.90% | 96.78% | 97.45% | -59.65% | -73.97% |
EPS Diluted | 98.70% | 98.88% | 98.99% | -253.70% | -366.17% |
Normalized Diluted EPS | 95.90% | 96.78% | 97.45% | -59.65% | -73.97% |
Average Basic Shares Outstanding | 197.57% | 607.53% | 5,388.28% | 1,774.54% | 638.08% |
Average Diluted Shares Outstanding | 197.57% | 607.53% | 5,388.28% | 1,774.54% | 638.08% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |